Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making
Tumori Journal · 2024
DOI: 10.1177/03008916241257754 ↗Kurz gefasst
Fallbericht in der Zeitschrift Tumori Journal, 2024. Verfasst von Fabiana Perrone und 11 weiteren Autor:innen. Beteiligte Einrichtung: Medical Oncology Unit, University Hospital of Parma, Parma, Italy. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Large Cell, Proto-Oncogene Proteins B-raf, Proto-Oncogene Proteins c-met. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 12 Literaturangaben.
Abstract (Originalsprache)
Introduction
Several biomarkers are currently available to address targeted treatments in cancer patients, with lung malignancies representing one of the best examples. Case description: We report the case of a patient affected by advanced non-small cell lung cancer with an uncommon histology and a complex biology. The use of a large next-generation sequencing (NGS) NGS panel allowed us to identify an extremely rare BRAF mutation (V600Q), a MET amplification, a high tumor mutational burden, a germline pathogenetic BRCA1 mutation and a homologous recombination deficiency through RAD51 assay. The treatment decision was driven by the abundance of molecular information.
Conclusions
This case highlights that an attentive and critical evaluation of molecular reports is key for the tailoring of treatment algorithms at the patient-level scale.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Medical Oncology Unit, University Hospital of Parma, Parma, Italy.
- Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, Massachusetts, USA.
- Pathology Unit, University Hospital of Parma, Parma, Italy.
- INSERM UMR981, Gustave Roussy Institute, Villejuif, France.
- Department of Medicine and Surgery, University of Parma, Parma, Italy.
- Oncology Clinic, Polytechnic University of Marche, United Hospitals of Ancona, Ancona, Italy.
ORCID-Profile: Fabiana Perrone, Letizia Gnetti, Valeria Cognigni
Zitieren
APA
Perrone, F., Facchinetti, F., Pellegrino, B., Minari, R., Gnetti, L., Azzoni, C., Bottarelli, L., Campanini, N., Grau-Bejar, J. F., Mingozzi, A., Cognigni, V., & Tiseo, M. (2024). Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making. Tumori Journal. https://doi.org/10.1177/03008916241257754
Vancouver
Perrone F, Facchinetti F, Pellegrino B, Minari R, Gnetti L, Azzoni C, et al. Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making. Tumori Journal. 2024. doi:10.1177/03008916241257754
BibTeX
@article{Perrone2024,
author = {Perrone, Fabiana and Facchinetti, Francesco and Pellegrino, Benedetta and Minari, Roberta and Gnetti, Letizia and Azzoni, Cinzia and Bottarelli, Lorena and Campanini, Nicoletta and Grau-Bejar, Juan Francisco and Mingozzi, Anna and Cognigni, Valeria and Tiseo, Marcello},
title = {Multiple targets, germline BRCA1 mutation and HRD in a lung cancer patient: Molecular considerations and treatment decision-making},
journal = {Tumori Journal},
year = {2024},
doi = {10.1177/03008916241257754}
}
EUVIMED